UBS Group
PMI

UBS Group’s Picard Medical PMI Stock Holding History

UBS Group’s Portfolio PMI Stock Details PMI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$20.5K Buy
2,504
+2,449
+4,453% +$52K ﹤0.01% 8153
2026
Q1 		$2.83K Sell
55
-602
-92% -$43.6K ﹤0.01% 9194
2025
Q4 		$57.5K Buy
657
+547
+497% +$129K ﹤0.01% 7157
2025
Q3 		$46.6K Buy
+110
New +$38.8K ﹤0.01% 7615

Other funds holding PMI

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
IC
IEQ Capital Foster City, California $21.7B AUM 77.3% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Cerity Partners
Cerity Partners New York $82.7B AUM 28.53% 1-Year Est. Return
Mariner
Mariner Overland Park, Kansas $95.2B AUM 32.92% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $36.8B AUM 42.13% 1-Year Est. Return

UBS Group's PMI Position: Q2 2026 in Review

UBS Group increased its Picard Medical (PMI) stake by 4,453% in Q2 2026, buying an estimated $52K and bringing the position to 2,504 shares worth $20.5K. The position accounts for ﹤0.01% of the portfolio, ranked #8153.

UBS Group first reported a position in PMI in Q3 2025 and has held it in 4 quarters since. The position peaked at $57.5K in Q4 2025. 41 funds tracked by Wall St. Rank hold PMI as of Q2 2026.

  • UBS Group held 2,504 shares of Picard Medical worth $20.5K as of Q2 2026.
  • UBS Group bought 2,449 Picard Medical shares in Q2 2026, an estimated $52K.
  • Picard Medical made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #8153 holding.
  • UBS Group first reported a position in Picard Medical in Q3 2025 and has held it in 4 quarters since.
  • UBS Group's Picard Medical position peaked at $57.5K in Q4 2025.
  • 41 funds tracked by Wall St. Rank held Picard Medical as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.